|
|
|
|
| LEADER |
04788nam a22002895i 4500 |
| 001 |
978-1-59259-324-8 |
| 005 |
20190618081800.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2003 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592593248
|
| 024 |
7 |
|
|a 10.1385/1592593240
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Lung Cancer
|b Volume 2: Diagnostic and Therapeutic Methods and Reviews /
|c edited by Barbara Driscoll.
|
| 250 |
|
|
|a 1st ed. 2003.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2003.
|
| 300 |
|
|
|a XXIII, 816 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Methods in Molecular Medicine,
|v 75
|
| 505 |
0 |
|
|a Molecular and Genetic Aspects of Lung Cancer -- Detection of Altered Tumor Markers in Clinical Samples for Diagnosis and Prognosis -- Molecular Alterations in Lung Cancer -- Cellular Predictive Factors of Drug Resistance in Non-Small Cell Lung Carcinomas -- Clinical Implications of p53 Mutations in Lung Cancer -- An Epidemiologic and Clinicopathologic Overview of AIDS-Associated Pulmonary Kaposi’s Sarcoma -- Myeloperoxidase Promoter Region Polymorphism and Lung Cancer Risk -- Clinical Utility of Tumor Markers in the Management of Non-Small Cell Lung Cancer -- Detection of Chromosomal Aberrations in Lung Tissue and Peripheral Blood Lymphocytes Using Interphase Fluorescence In Situ Hybridization (FISH) -- In Situ Analysis of Telomerase RNA Gene Expression as a Marker for Tumor Progression -- A High-Throughput Methodology for Identifying Molecular Targets Overexpressed in Lung Cancers -- Expression Profiling of Lung Cancer Based on Suppression Subtraction Hybridization (SSH) -- Comparative Genomic Hybridization of Human Lung Cancer -- Sensitive Assays for Detection of Lung Cancer -- Fluorescent Microsatellite Analysis in Bronchial Lavage as a Potential Diagnostic Tool for Lung Cancer -- Southern Blotting of Genomic DNA from Lung and Its Tumors -- Assessment of Insulin-Like Growth Factors and Mutagen Sensitivity as Predictors of Lung Cancer Risk -- Comparative Multiplex PCR and Allele-Specific Expression Analysis in Human Lung Cancer -- Detection of K-ras Point Mutations in Sputum from Patients with Adenocarcinoma of the Lung by Point-EXACCT -- Detection of K-ras and p53 Mutations by “Mutant-Enriched” PCR-RFLP -- Detection of Small Cell Lung Cancer by RT-PCR for Neuropeptides, Neuropeptide Receptors, or a Splice Variant of the Neuron Restrictive Silencer Factor -- Utilization of Thyroid Transcription Factor-1 Immunostaining in the Diagnosis of Lung Tumors -- Molecular Biologic Substaging of Stage I NSCLC Through Immunohistochemistry Performed on Formalin-Fixed, Paraffin-Embedded Tissue -- A Sensitive Immunofluorescence Assay for Detection of p53 Protein in the Sputum -- SPR1 -- Determination of Biological Parameters on Fine-Needle Aspirates from Non-Small Cell Lung Cancer -- Detection and Analysis of Lung Cancer Cells from Body Fluids Using a Rare Event Imaging System -- Reconstruction of Geno-Phenotypic Evolutionary Sequences from Intracellular Patterns of Molecular Abnormalities in Human Solid Tumors -- Novel Therapies -- Surgical Treatment of Lung Cancer -- Recent Advances and Dilemmas in the Radiotherapeutic Management of Locally Advanced Non-Small Cell Lung Cancer -- Photodynamic Therapy in Lung Cancer -- Gene Therapy for Lung Cancer -- Identifying Obstacles to Viral Gene Therapy for Lung Cancer -- Topical Gene Therapy for Pulmonary Diseases with PEI-DNA Aerosol Complexes -- Targeted Delivery of Expression Plasmids to the Lung via Macroaggregated Polyethylenimine-Albumin Conjugates -- Preparation of Retroviral Vectors for Cell-Cycle-Targeted Gene Therapy of Lung Cancer -- Aerosol Gene Therapy for Metastatic Lung Cancer Using PEI-p53 Complexes -- Clinical Development of Antisense Oligonucleotides as Anti-Cancer Therapeutics -- Antisense Oligonucleotides Targeting RI? Subunit of Protein Kinase A -- Use of Antisense Oligonucleotides for Therapy -- Induction of Programmed Cell Death with an Antisense Bcl-2 Oligonucleotide -- Tumor Vaccination with Cytokine-Encapsulated Microspheres -- Adoptive Immunotherapy -- Intratumoral Therapy with Cytokine Gene-Modified Dendritic Cells in Murine Lung Cancer Models -- Cyclooxygenase 2-Dependent Regulation of Antitumor Immunity in Lung Cancer -- Chemoprevention of Lung Cancer -- Assessing the Interaction of Particulate Delivery Systems with Lung Surfactant -- Chemopreventive Therapeutics.
|
| 650 |
|
0 |
|a Oncology .
|
| 650 |
1 |
4 |
|a Oncology.
|
| 700 |
1 |
|
|a Driscoll, Barbara.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1385/1592593240
|